LUNG vs CERS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 03, 2026
LUNG
CERS
Investment Advisor Scores
CERS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | LUNG | CERS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 28.3286 | 0 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -4.6% | 9.5% | CERS |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 55.1/100 | 38.2/100 | LUNG |
| Profit Margin | -55.0% | -3.1% | CERS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | LUNG |
Relative Price Performance (Last 90 Days)
Current Technical Phase
LUNG
NeutralMixed signals - no dominant trend phase, RSI 40
CERS
MarkdownPrice below a falling SMA50 (slope -7.9%), weak momentum, RSI 33
Fundamentals Snapshot
| Metric | LUNG | CERS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -1.9 | -456.0 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.1% |
| Gross Margin | 0.8% | 0.5% |
| Operating Margin | -0.4% | 0.0% |
| EPS | -1.15 | -0.03 |
| Dividend Yield | — | — |